Skip to main content
Journal cover image

Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.

Publication ,  Journal Article
Bethel, MA; Sourij, H; Stevens, SR; Hannan, K; Lokhnygina, Y; Adler, AI; Peterson, ED; Holman, RR; Lopes, RD
Published in: Cardiovasc Diabetol
March 28, 2023

BACKGROUND: Estimating cardiovascular (CV) event accrual is important for outcome trial planning. Limited data exist describing event accrual patterns in patients with type 2 diabetes (T2D). We compared apparent CV event accrual patterns with true event rates in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). METHODS: Centrally adjudicated event dates and accrual rates for a 4-point major adverse CV event composite (MACE-4; includes CV death, nonfatal myocardial infarction, nonfatal stroke, or unstable angina hospitalization), MACE-4 components, all-cause mortality (ACM), and heart failure hospitalization were compiled. We used three graphical methods (Weibull probability plot, plot of negative log of the Kaplan-Meier survival distribution estimate, and the Epanechnikov kernel-smoothed estimate of the hazard rate) to examine hazard rate morphology over time for the 7 outcomes. RESULTS: Plots for all outcomes showed real-time constant event hazard rates for the duration of the follow-up, confirmed by Weibull shape parameters. The Weibull shape parameters for ACM (1.14, 95% CI 1.08-1.21) and CV death (1.08, 95% CI 1.01-1.16) were not sufficiently > 1 as to require non-constant hazard rate models to accurately depict the data. The time lag between event occurrence and event adjudication being completed, the adjudication gap, improved over the course of the trial. CONCLUSIONS: In TECOS, the nonfatal event hazard rates were constant over time. Small increases over time in the hazard rate for fatal events would not require complex modelling to predict event accrual, providing confidence in traditional modelling methods for predicting CV outcome trial event rates in this population. The adjudication gap provides a useful metric to monitor within-trial event accrual patterns. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov NCT00790205.

Duke Scholars

Published In

Cardiovasc Diabetol

DOI

EISSN

1475-2840

Publication Date

March 28, 2023

Volume

22

Issue

1

Start / End Page

72

Location

England

Related Subject Headings

  • Sitagliptin Phosphate
  • Myocardial Infarction
  • Hypoglycemic Agents
  • Humans
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Atherosclerosis
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bethel, M. A., Sourij, H., Stevens, S. R., Hannan, K., Lokhnygina, Y., Adler, A. I., … Lopes, R. D. (2023). Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Cardiovasc Diabetol, 22(1), 72. https://doi.org/10.1186/s12933-023-01802-x
Bethel, M Angelyn, Harald Sourij, Susanna R. Stevens, Karen Hannan, Yuliya Lokhnygina, Amanda I. Adler, Eric D. Peterson, Rury R. Holman, and Renato D. Lopes. “Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.Cardiovasc Diabetol 22, no. 1 (March 28, 2023): 72. https://doi.org/10.1186/s12933-023-01802-x.
Bethel MA, Sourij H, Stevens SR, Hannan K, Lokhnygina Y, Adler AI, et al. Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 2023 Mar 28;22(1):72.
Bethel, M. Angelyn, et al. “Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.Cardiovasc Diabetol, vol. 22, no. 1, Mar. 2023, p. 72. Pubmed, doi:10.1186/s12933-023-01802-x.
Bethel MA, Sourij H, Stevens SR, Hannan K, Lokhnygina Y, Adler AI, Peterson ED, Holman RR, Lopes RD. Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 2023 Mar 28;22(1):72.
Journal cover image

Published In

Cardiovasc Diabetol

DOI

EISSN

1475-2840

Publication Date

March 28, 2023

Volume

22

Issue

1

Start / End Page

72

Location

England

Related Subject Headings

  • Sitagliptin Phosphate
  • Myocardial Infarction
  • Hypoglycemic Agents
  • Humans
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Atherosclerosis
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology